
HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY
Click and Sign Up to Get Live Updates on Q2 Results
Updated: 17 Oct 2025 • 2:49 pm
Posted by:

HDB Financial Q2 Results FY26: HDB Financial posted its Q2 results on 15th October 2025. The company posted robust numbers, with Q2 PAT standing at ₹581 crores against revenue of ₹4,545 crores. During Q2 FY26, the profit decrease of the company was recorded at 1.5% YoY, and the revenue increase for the same period was 13.42%.
HDB Financial Q2 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
| Particulars | Quarter Ended | |
| 30-09-2025 | 30-09-2024 | |
| Revenue from Operations | ₹4,545 | ₹4,007 |
| Profit Before Tax (PBT) | ₹3.51 | ₹2.92 |
| Profit After Tax (PAT) | ₹581 | ₹591 |
(Figures in crores)
HDB Financial Q2 Results FY26 Highlights (Q2 FY26 vs FY25)
- HDB Financial clocked Q2 FY26 consolidated revenue of ₹4,545 crores vs ₹4,007 crores.
- On the profit front, HDB Financial earned a consolidated PAT of ₹581 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹591 crore.
- As per the consolidated figures, the quarterly PAT of HDB Financial has decreased by 1.5%, and revenue has decreased by 13.42% YoY.
HDB Financial Share Price Performance
On the opening bell of 16th October 2025, the shares of HDB Financial opened at ₹740.00 per share. However, the initial gains have been wiped out as of now, and HDB Financial shares are trading at ₹737.40 per share, lower than their opening price.
Considering the long-term performance, HDB Financial shares have yielded close to -11.50% returns in the past 1 year, and 5-year returns stand at 11.50%. Over the maximum timeframe, the HDB Financial share provided 10.98% returns to investors.
What Analysts Expect Post Q2 Results?
As HDB Financial has posted robust Q2 results for FY26, analysts are expecting positive trends in its share price. As per the analysts, HDB Financial’s share price could reach ₹790.20 per share in the coming year, and in downtrends, the share price could hit the level of ₹695.40 per share. However, one must ignore the risk of volatility in the stock market and invest in HDB Financial’s shares after thorough research.
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
Classic Electrodes IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Shivashrit Foods IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Hero Motors IPO Details: Everything You Should Know about
Anondita Medicare IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Upcoming IPO: Abril Paper Tech, Rachit Prints & Amanta Healthcare
Mangal Electrical IPO Listing Preview: What to Expect Now?
LG Electronics IPO Details: Everything You Should Know about
Recent Articles

Nifty IT Falls 1.7% on June 8, 2026 and Is Down 8% in 4 Sessions as AI Trade Reverses and Global Tech Selloff Hits Infosys, TCS and Wipro
8 June 2026

Manomay Tex India Share Analyst Review: CMP, Performance, Target and 2026 Outlook
8 June 2026

Alembic Pharma Share Price Climbs on June 8, 2026 After Canada JV with Difgen Holdings and USFDA Approval for Haloperidol Tablets
8 June 2026

Udayshivakumar Infra Share Analyst Review: CMP, Performance, Target and 2026 Outlook
8 June 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Nifty IT Falls 1.7% on June 8, 2026 and Is Down 8% in 4 Sessions as AI Trade Reverses and Global Tech Selloff Hits Infosys, TCS and Wipro
Manomay Tex India Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Alembic Pharma Share Price Climbs on June 8, 2026 After Canada JV with Difgen Holdings and USFDA Approval for Haloperidol Tablets
Udayshivakumar Infra Share Analyst Review: CMP, Performance, Target and 2026 Outlook
IndiGo Share Price Falls 2.5% on June 8, 2026 as Crude Oil Spike and Airbus Delivery Concerns Hit Aviation Sector
Popular this week
Nifty IT Falls 1.7% on June 8, 2026 and Is Down 8% in 4 Sessions as AI Trade Reverses and Global Tech Selloff Hits Infosys, TCS and Wipro
Manomay Tex India Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Alembic Pharma Share Price Climbs on June 8, 2026 After Canada JV with Difgen Holdings and USFDA Approval for Haloperidol Tablets
Udayshivakumar Infra Share Analyst Review: CMP, Performance, Target and 2026 Outlook
IndiGo Share Price Falls 2.5% on June 8, 2026 as Crude Oil Spike and Airbus Delivery Concerns Hit Aviation Sector

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





